Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/24/26 18:58 | 6/22/26 | FTH | Health | Drug | Pharmaceutical Preparations | Stephenson Brian C | TX | O | CFO | 1 | P.m | 406 | 23.31 | 0 | 17 | 17 | I | |||||||||||||||
6/24/26 18:55 | 6/22/26 | FTH | Health | Drug | Pharmaceutical Preparations | Parikh Anand Kiran | TX | DO | P,CEO | 2 | P.d | 117 | 2.09 | 0 | 56 | 7 | 818 | D | ||||||||||||||
6/24/26 18:55 | 6/22/26 | FTH | Health | Drug | Pharmaceutical Preparations | Parikh Anand Kiran | TX | DO | P,CEO | 2 | M.d | 117 | 2.09 | 0 | 56 | 7 | 818 | D | ||||||||||||||
6/1/26 17:21 | 6/1/26 | SNSE | Health | Drug | Pharmaceutical Preparations | Cambrian Biopharma Inc | NY | T | 1 | S | -501 | 20.02 | 0 | -25 | 130 | D | ||||||||||||||||
6/1/26 17:20 | 6/1/26 | SNSE | Health | Drug | Pharmaceutical Preparations | Peyer James | NY | TH | See rema | 1 | S | -501 | 20.02 | 0 | -25 | 130 | D | |||||||||||||||
5/15/26 16:24 | 4/2/26 | SNSE | Health | Drug | Pharmaceutical Preparations | Millennium Management LLC | NY | T | 6 | P.m | 2,046 | 29.21 | 0 | 70 | 90 | 148 | I | |||||||||||||||
5/15/26 16:24 | 4/2/26 | SNSE | Health | Drug | Pharmaceutical Preparations | Millennium Management LLC | NY | T | 6 | S.m | -2,046 | 29.21 | 0 | -70 | 148 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |